199 related articles for article (PubMed ID: 34831156)
1. Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study.
Lee H; Chien RN; Pao LH; Kuo CJ; Huang PH; Chang ML
Cells; 2021 Oct; 10(11):. PubMed ID: 34831156
[TBL] [Abstract][Full Text] [Related]
2. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
[TBL] [Abstract][Full Text] [Related]
3. INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?
Andrade VG; Yamashiro FDS; Oliveira CV; Kurozawa LL; Moreira A; Silva GF
Arq Gastroenterol; 2018; 55(2):184-187. PubMed ID: 30043871
[TBL] [Abstract][Full Text] [Related]
4. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
[TBL] [Abstract][Full Text] [Related]
5. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.
Jung HJ; Kim YS; Kim SG; Lee YN; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS
Clin Mol Hepatol; 2014 Mar; 20(1):38-46. PubMed ID: 24757657
[TBL] [Abstract][Full Text] [Related]
6. Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
Butt AA; Umbleja T; Andersen JW; Sherman KE; Chung RT;
Clin Infect Dis; 2012 Sep; 55(5):631-8. PubMed ID: 22563020
[TBL] [Abstract][Full Text] [Related]
7. Evolution of ferritin levels in hepatitis C patients treated with antivirals.
Chang ML; Hu JH; Yen CH; Chen KH; Kuo CJ; Lin MS; Lee CH; Chen SC; Chien RN
Sci Rep; 2020 Nov; 10(1):19744. PubMed ID: 33184464
[TBL] [Abstract][Full Text] [Related]
8. Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity.
Chang ML; Kuo CJ; Huang HC; Chu YY; Chiu CT
PLoS One; 2016; 11(11):e0166712. PubMed ID: 27870883
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.
Russo FP; Zanetto A; Gambato M; Bortoluzzi I; Al Zoairy R; Franceschet E; De Marchi F; Marzi L; Lynch EN; Floreani A; Farinati F; Schaefer B; Burra P; Zoller H; Mega A
J Viral Hepat; 2020 Feb; 27(2):188-194. PubMed ID: 31596996
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals.
Casas-Deza D; Espina S; Martínez-Sapiña A; Del Moral-Bergos R; Garcia-Sobreviela MP; Lopez-Yus M; Calmarza P; Bernal-Monterde V; Arbones-Mainar JM
Atherosclerosis; 2023 Jun; 375():59-66. PubMed ID: 37245427
[TBL] [Abstract][Full Text] [Related]
11. Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation.
Chang SW; Cheng ML; Shiao MS; Yeh CT; Wang CH; Fan CM; Chiu CT; Chang ML
J Clin Lipidol; 2018; 12(3):756-766. PubMed ID: 29574072
[TBL] [Abstract][Full Text] [Related]
12. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
[TBL] [Abstract][Full Text] [Related]
13. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents.
Cheng PN; Sun HY; Feng IC; Chiu YC; Wang ST; Tan DC; Chiu HC; Chien SC; Young KC
J Microbiol Immunol Infect; 2023 Feb; 56(1):20-30. PubMed ID: 35842406
[TBL] [Abstract][Full Text] [Related]
14. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens.
Carvalho JR; Velosa J; Serejo F
Scand J Gastroenterol; 2018; 53(7):857-863. PubMed ID: 29779403
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients.
Khattab M; Eslam M; Sharwae MA; Shatat M; Ali A; Hamdy L
Am J Gastroenterol; 2010 Sep; 105(9):1970-7. PubMed ID: 20234345
[TBL] [Abstract][Full Text] [Related]
16. The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?
Özdoğan O; Yaraş S; Ateş F; Üçbilek E; Sezgin O; Altıntaş E
Turk J Gastroenterol; 2020 May; 31(5):384-392. PubMed ID: 32519958
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
[TBL] [Abstract][Full Text] [Related]
18. Critical role of triglycerides for adiponectin levels in hepatitis C: a joint study of human and HCV core transgenic mice.
Chang ML; Hu JH; Pao LH; Lin MS; Kuo CJ; Chen SC; Fan CM; Chang MY; Chien RN
BMC Immunol; 2021 Aug; 22(1):54. PubMed ID: 34380427
[TBL] [Abstract][Full Text] [Related]
19. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
Ferreira J; Bicho M; Serejo F
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543737
[TBL] [Abstract][Full Text] [Related]
20. Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response?
Mousa N; Abdel-Razik A; Farag R; Shabana W; Elgamal A; El-Wakeel N; Elzehery R; Elkashef W; Eldars W
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1004-1009. PubMed ID: 28749790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
